Quantcast

Posts related to ‘NicVax’

The Day After the Implosion: How Long Can Nabi Survive? (NABI)

Nabi Biopharmaceuticals (NASDAQ: NABI) actually finds itself in a strange situation after Monday's awful news that its NicVAX nicotine conjugate immunotherapeutic failed to meet its primary endpoint in the first ...
Read Full Story »